107 related articles for article (PubMed ID: 18436228)
1. Lipocalin-type prostaglandin D synthase is a powerful biomarker for severity of stable coronary artery disease.
Inoue T; Eguchi Y; Matsumoto T; Kijima Y; Kato Y; Ozaki Y; Waseda K; Oda H; Seiki K; Node K; Urade Y
Atherosclerosis; 2008 Dec; 201(2):385-91. PubMed ID: 18436228
[TBL] [Abstract][Full Text] [Related]
2. Serum prostaglandin D synthase level after coronary angioplasty may predict occurrence of restenosis.
Inoue T; Takayanagi K; Morooka S; Uehara Y; Oda H; Seiki K; Nakajima H; Urade Y
Thromb Haemost; 2001 Jan; 85(1):165-70. PubMed ID: 11204569
[TBL] [Abstract][Full Text] [Related]
3. Association of serum lipocalin-type prostaglandin D synthase levels with subclinical atherosclerosis in untreated asymptomatic subjects.
Miwa Y; Oda H; Shiina Y; Shikata K; Tsushima M; Nakano S; Maruyama T; Kyotani S; Eguchi N; Urade Y; Takahashi-Yanaga F; Morimoto S; Sasaguri T
Hypertens Res; 2008 Oct; 31(10):1931-9. PubMed ID: 19015601
[TBL] [Abstract][Full Text] [Related]
4. A urine biomarker for severe obstructive sleep apnoea patients: lipocalin-type prostaglandin D synthase.
Chihara Y; Chin K; Aritake K; Harada Y; Toyama Y; Murase K; Yoshimura C; Hitomi T; Oga T; Mishima M; Urade Y
Eur Respir J; 2013 Dec; 42(6):1563-74. PubMed ID: 23222881
[TBL] [Abstract][Full Text] [Related]
5. Lipocalin-type prostaglandin D synthase is associated with coronary vasospasm and vasomotor reactivity in response to acetylcholine.
Matsumoto T; Eguchi Y; Oda H; Yamane T; Tarutani Y; Ozawa T; Hayashi H; Nakae I; Horie M; Urade Y
Circ J; 2011; 75(4):897-904. PubMed ID: 21325722
[TBL] [Abstract][Full Text] [Related]
6. Central nervous system lipocalin-type prostaglandin D2-synthase is correlated with orexigenic neuropeptides, visceral adiposity and markers of the hypothalamic-pituitary-adrenal axis in obese humans.
Elias E; Benrick A; Behre CJ; Ekman R; Zetterberg H; Stenlöf K; Wallenius V
J Neuroendocrinol; 2011 Jun; 23(6):501-7. PubMed ID: 21438929
[TBL] [Abstract][Full Text] [Related]
7. Lipocalin-type prostaglandin D synthase is not a biomarker of atherosclerotic manifestations.
Hosbond SE; Diederichsen AC; Pedersen L; Rasmussen LM; Munkholm H; Gerke O; Poulsen TS; Mickley H
Scand J Clin Lab Invest; 2014 Apr; 74(3):219-27. PubMed ID: 24456422
[TBL] [Abstract][Full Text] [Related]
8. Seminal plasma lipocalin-type prostaglandin D synthase: a potential new marker for the diagnosis of obstructive azoospermia.
Heshmat SM; Mullen JB; Jarvi KA; Soosaipillai A; Diamandis EP; Hamilton RJ; Lo KC
J Urol; 2008 Mar; 179(3):1077-80. PubMed ID: 18206953
[TBL] [Abstract][Full Text] [Related]
9. Lipocalin-type prostaglandin D synthase levels are associated with the severity of pulmonary embolism.
Mutlu H; Kokulu K; Sert ET; Çağlar A
Heart Vessels; 2020 Jul; 35(7):996-1002. PubMed ID: 32076814
[TBL] [Abstract][Full Text] [Related]
10. Prevention of paraquat-induced apoptosis in human neuronal SH-SY5Y cells by lipocalin-type prostaglandin D synthase.
Fujimori K; Fukuhara A; Inui T; Allhorn M
J Neurochem; 2012 Jan; 120(2):279-91. PubMed ID: 22043816
[TBL] [Abstract][Full Text] [Related]
11. The lipocalins retinol-binding protein-4, lipocalin-2 and lipocalin-type prostaglandin D2-synthase correlate with markers of inflammatory activity, alcohol intake and blood lipids, but not with insulin sensitivity in metabolically healthy 58-year-old Swedish men.
Wallenius V; Elias E; Bergstrom GM; Zetterberg H; Behre CJ
Exp Clin Endocrinol Diabetes; 2011 Feb; 119(2):75-80. PubMed ID: 21104585
[TBL] [Abstract][Full Text] [Related]
12. Role of Lipocalin-type prostaglandin D2 synthase (L-PGDS) and its metabolite, prostaglandin D2, in preterm birth.
Kumar S; Palaia T; Hall CE; Ragolia L
Prostaglandins Other Lipid Mediat; 2015; 118-119():28-33. PubMed ID: 25964109
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of recombinant human lipocalin-type prostaglandin D synthase/beta-trace in canine.
Li W; Mase M; Inui T; Shimoda M; Isomura K; Oda H; Yamada K; Urade Y
Neurosci Res; 2008 Jul; 61(3):289-93. PubMed ID: 18471915
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of prostaglandin D(2) production through cyclooxygenase-2 and lipocalin-type prostaglandin D synthase by upstream stimulatory factor 1 in human brain-derived TE671 cells under serum starvation.
Fujimori K; Aritake K; Urade Y
Gene; 2008 Dec; 426(1-2):72-80. PubMed ID: 18817855
[TBL] [Abstract][Full Text] [Related]
15. Relationship between lipocalin-type prostaglandin D synthase and alpha-glucosidase in azoospermia seminal plasma.
Chen DY; Wang JJ; Huang YF; Zhou KY
Clin Chim Acta; 2005 Apr; 354(1-2):69-76. PubMed ID: 15748601
[TBL] [Abstract][Full Text] [Related]
16. Urinary excretions of lipocalin-type prostaglandin D synthase predict renal injury in type-2 diabetes: a cross-sectional and prospective multicentre study.
Uehara Y; Makino H; Seiki K; Urade Y;
Nephrol Dial Transplant; 2009 Feb; 24(2):475-82. PubMed ID: 18799608
[TBL] [Abstract][Full Text] [Related]
17. Blood sugar control reverses the increase in urinary excretion of prostaglandin D synthase in diabetic patients.
Hamano K; Totsuka Y; Ajima M; Gomi T; Ikeda T; Hirawa N; Eguchi Y; Yamakado M; Takagi M; Nakajima H; Oda H; Seiki K; Eguchi N; Urade Y; Uehara Y
Nephron; 2002 Sep; 92(1):77-85. PubMed ID: 12187088
[TBL] [Abstract][Full Text] [Related]
18. Changes of lipocalin-type prostaglandin D synthase level during pregnancy.
Shiki Y; Shimoya K; Tokugawa Y; Kimura T; Koyama M; Azuma C; Murata Y; Eguchi N; Oda H; Urade Y
J Obstet Gynaecol Res; 2004 Feb; 30(1):65-70. PubMed ID: 14718024
[TBL] [Abstract][Full Text] [Related]
19. Sustained expression of lipocalin-type prostaglandin D synthase in the antisense direction positively regulates adipogenesis in cloned cultured preadipocytes.
Chowdhury AA; Hossain MS; Rahman MS; Nishimura K; Jisaka M; Nagaya T; Shono F; Yokota K
Biochem Biophys Res Commun; 2011 Jul; 411(2):287-92. PubMed ID: 21726533
[TBL] [Abstract][Full Text] [Related]
20. Development and evaluation of a practical ELISA for human urinary lipocalin-type prostaglandin D synthase.
Oda H; Shiina Y; Seiki K; Sato N; Eguchi N; Urade Y
Clin Chem; 2002 Sep; 48(9):1445-53. PubMed ID: 12194921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
